The King of Ozempic Is Scared as Hell
Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?
Read MoreThe ugly side of weight loss drugs is revealing itself
These medications have amplified fatphobia in our culture
Read MoreEnd of content
No more pages to load